arrow
A

Alastair Greystoke

Newcastle upon Tyne Hospitals NHS Foundation Trust
H指数:36
被引数:6,727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Project Optimus for Radiation Therapy–Drug Combinations: Moving Beyond the Maximum Tolerated Dose

Project Optimus计划用于放射疗法-药物联合治疗:超越最大耐受剂量

2026-07-300
PRE
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology

Experimental Cancer Medicine Centre (ECMC)网络关于泛癌种测序的共识基因面板的提案:一种德尔菲方法

2025-11-080
OAAI
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer

分子肿瘤委员会:国际肺癌研究协会的共识声明

2025-07-070
PRE
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial

德法替尼联合阿瓦替尼治疗实体瘤患者: 1期框架试验

2025-06-270
OAAI
Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study

真实世界中,携带表皮生长因子受体外显子20插入突变的晚期非小细胞肺癌患者的前线治疗方案,以及PAPILLON研究中与阿曼曲单抗联合化疗的调整后比较。

2025-05-010
PRE
Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies

SCNS-Target的开发:一种用于评估接受免疫治疗、生物治疗或精准疗法的癌症患者未满足需求的新工具

2025-04-100
OA
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy

Pembrolizumab联合或不维持Olaparib用于转移性鳞状NSCLC,对一线Pembrolizumab加化疗有反应

2025-02-011
OAAI
The care of older patients with cancer across the United Kingdom in 2024: A narrative review by the International Society of Geriatric Oncology UK Country Group
2025-01-010
PRE
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial☆

羟氯喹联合铂类双药化疗作为广泛期小细胞肺癌的一线治疗(研究15):一项随机II期多中心试验☆

2025-01-011
PRE
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的护理: 在早期临床试验中整合患者报告的结果进行耐受性评估-来自专家虚拟圆桌会议的见解

2024-10-010
OAAI
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
2024-10-010
OAAI